Portfolio Spotlight Ep 6: Hummingbird Bioscience with Co-Founder & CEO, Piers Ingram
In biotech, translating bold ideas into real-world therapies is a long game. Scientific breakthroughs often take years — sometimes decades — to reach the clinic. For Singapore-headquartered Hummingbird Bioscience, that journey is no exception. But it’s also a story that reveals how the right ecosystem, patient capital, and strategic partnerships can turn that long road into meaningful progress.
- 28 07 2025
- |
All
Stories & Videos
Insights & Trends
Portfolio News
Announcements
E-Newsletters
Events
Tab Item Content
Tab Item Content
Discover Insights and Trends
Circles – Reshaping the Telco industry from Singapore to the World
- 12 09 2024
- |
A recipe for success: How to thrive in Southeast Asia alternative protein market
- 11 07 2023
- |
What to watch in the biomedical space over the next five years
- 23 02 2023
- |
Enhancing the development of the ASEAN markets and accelerating global market expansion for Chinese biopharma companies
- 20 12 2020
- |
Racing toward the future: Artificial Intelligence in Southeast Asia
- 08 10 2020
- |
Tab Item Content
Tab Item Content
Tab Item Content
Tab Item Content